VYNT - Vyant Bio GAAP EPS of -$0.62 beats by $0.08 revenue of $0.15M November, 15 2022 08:22 AM Vyant Bio Inc. Vyant Bio press release ( NASDAQ: VYNT ): Q3 GAAP EPS of -$0.62 beats by $0.08 . Revenue of $0.15M (-42.3% Y/Y). Shares -2.63% PM. For further details see: Vyant Bio GAAP EPS of -$0.62 beats by $0.08, revenue of $0.15M